Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy (Q39476718)

12 September 2017

title

Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy (English)

1 reference

12 September 2017

1 reference

Liebross RH

1

1 reference

12 September 2017

Pollack A

2

1 reference

12 September 2017

Lankford SP

3

1 reference

12 September 2017

von Eschenbach AC

4

1 reference

12 September 2017

Zagars GK

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

12 September 2017

1 reference

12 September 2017

volume

52

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

647-652

1 reference

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Carcinoma of the prostate: value of transrectal sonography in detecting extension into the neurovascular bundle

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Ultrasound findings are not useful for defining stage T1c prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Prostate-specific antigen detected prostate cancer: pathological characteristics of ultrasound visible versus ultrasound invisible tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Predictive value of contralateral biopsies in unilaterally palpable prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Radiation therapy as treatment for stage T1c prostate cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900273-8

7 January 2021

10.1016/S0090-4295(98)00273-8

Identifiers

DOI

1 reference

12 September 2017

1 reference